167 related articles for article (PubMed ID: 29386474)
1. Long-Term Clinical Outcomes Survey of Bone Marrow-Derived Cell Therapy in Critical Limb Ischemia in Japan.
Kondo K; Yanishi K; Hayashida R; Shintani S; Shibata R; Murotani K; Ando M; Mizuno M; Fujiwara T; Murohara T; Matoba S;
Circ J; 2018 Mar; 82(4):1168-1178. PubMed ID: 29386474
[TBL] [Abstract][Full Text] [Related]
2. Impact of Therapeutic Angiogenesis Using Autologous Bone Marrow-Derived Mononuclear Cells Implantation in Critical Limb Ischemia With Scleroderma - Subanalysis of the Long-Term Clinical Outcomes Survey.
Shoji K; Yanishi K; Yoshimi R; Hamada N; Kondo K; Fujimoto K; Nakajima H; Kuwahara K; Higashi Y; Fukumoto Y; Murohara T; Matoba S;
Circ J; 2019 Feb; 83(3):662-671. PubMed ID: 30726805
[TBL] [Abstract][Full Text] [Related]
3. Autologous cells derived from different sources and administered using different regimens for 'no-option' critical lower limb ischaemia patients.
Abdul Wahid SF; Ismail NA; Wan Jamaludin WF; Muhamad NA; Abdul Hamid MKA; Harunarashid H; Lai NM
Cochrane Database Syst Rev; 2018 Aug; 8(8):CD010747. PubMed ID: 30155883
[TBL] [Abstract][Full Text] [Related]
4. Clinical features and predictors of patients with critical limb ischemia who responded to autologous mononuclear cell transplantation for therapeutic angiogenesis.
Aoyama N; Nishinari M; Ohtani S; Kanai A; Noda C; Hirata M; Miyamoto A; Watanabe M; Minamino T; Izumi T; Ako J
Heart Vessels; 2017 Sep; 32(9):1099-1108. PubMed ID: 28357515
[TBL] [Abstract][Full Text] [Related]
5. Long-Term Clinical Outcomes of Autologous Bone Marrow Mononuclear Cell Implantation in Patients With Severe Thromboangiitis Obliterans.
Mohamad Yusoff F; Kajikawa M; Takaeko Y; Kishimoto S; Hashimoto H; Maruhashi T; Kihara Y; Nakashima A; Higashi Y
Circ J; 2020 Mar; 84(4):650-655. PubMed ID: 32132348
[TBL] [Abstract][Full Text] [Related]
6. A Multicenter Prospective Interventional Trial of Therapeutic Angiogenesis Using Bone Marrow-Derived Mononuclear Cell Implantation for Patients With Critical Limb-Threatening Ischemia Caused by Thromboangiitis Obliterans.
Fujioka A; Yanishi K; Yukawa A; Imai K; Yokota I; Fujikawa K; Yamada A; Naito A; Shoji K; Kawamata H; Higashi Y; Ishigami T; Sasaki KI; Tara S; Kuwahara K; Teramukai S; Matoba S
Circ J; 2023 Aug; 87(9):1229-1237. PubMed ID: 36908168
[TBL] [Abstract][Full Text] [Related]
7. Impact of Therapeutic Angiogenesis Using Autologous Bone Marrow-derived Mononuclear Cell Implantation in Patients with No-option Critical Limb Ischemia.
Yanishi K; Shoji K; Fujioka A; Hori Y; Yukawa A; Matoba S
Ann Vasc Dis; 2020 Mar; 13(1):13-22. PubMed ID: 32273917
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic Efficacy of Autologous Non-Mobilized Enriched Circulating Endothelial Progenitors in Patients With Critical Limb Ischemia - The SCELTA Trial.
Liotta F; Annunziato F; Castellani S; Boddi M; Alterini B; Castellini G; Mazzanti B; Cosmi L; Acquafresca M; Bartalesi F; Dilaghi B; Dorigo W; Graziani G; Bartolozzi B; Bellandi G; Carli G; Bartoloni A; Fargion A; Fassio F; Fontanari P; Landini G; Lucente EAM; Michelagnoli S; Orsi Battaglini C; Panigada G; Pigozzi C; Querci V; Santarlasci V; Parronchi P; Troisi N; Baggiore C; Romagnani P; Mannucci E; Saccardi R; Pratesi C; Gensini G; Romagnani S; Maggi E
Circ J; 2018 May; 82(6):1688-1698. PubMed ID: 29576595
[TBL] [Abstract][Full Text] [Related]
9. Relationship between cell number and clinical outcomes of autologous bone-marrow mononuclear cell implantation in critical limb ischemia.
Yusoff FM; Kajikawa M; Takaeko Y; Kishimoto S; Hashimoto H; Maruhashi T; Nakashima A; Wahid SFSA; Higashi Y
Sci Rep; 2020 Nov; 10(1):19891. PubMed ID: 33199760
[TBL] [Abstract][Full Text] [Related]
10. Early endothelial progenitor cells in bone marrow are a biomarker of cell therapy success in patients with critical limb ischemia.
Smadja DM; Duong-van-Huyen JP; Dal Cortivo L; Blanchard A; Bruneval P; Emmerich J; Gaussem P
Cytotherapy; 2012 Feb; 14(2):232-9. PubMed ID: 22040109
[TBL] [Abstract][Full Text] [Related]
11. [A FOLLOW-UP STUDY ON AUTOLOGOUS BONE MARROW MONONUCLEAR CELLS TRANSPLANTATION FOR CRITICAL LOWER ARTERIOSCLEROSIS OBLITERANS IN DIABETIC PATIENTS].
Dou Y; Zhao J; Zhang L; Wang X; Yuan H; Yuan C
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2015 Jul; 29(7):893-8. PubMed ID: 26540987
[TBL] [Abstract][Full Text] [Related]
12. Autologous bone-marrow mononuclear cell implantation reduces long-term major amputation risk in patients with critical limb ischemia: a comparison of atherosclerotic peripheral arterial disease and Buerger disease.
Idei N; Soga J; Hata T; Fujii Y; Fujimura N; Mikami S; Maruhashi T; Nishioka K; Hidaka T; Kihara Y; Chowdhury M; Noma K; Taguchi A; Chayama K; Sueda T; Higashi Y
Circ Cardiovasc Interv; 2011 Feb; 4(1):15-25. PubMed ID: 21205941
[TBL] [Abstract][Full Text] [Related]
13. Characteristics of responders to autologous bone marrow cell therapy for no-option critical limb ischemia.
Madaric J; Klepanec A; Valachovicova M; Mistrik M; Bucova M; Olejarova I; Necpal R; Madaricova T; Paulis L; Vulev I
Stem Cell Res Ther; 2016 Aug; 7(1):116. PubMed ID: 27530339
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and Safety of Autologous Cell-based Therapy in Patients with No-option Critical Limb Ischaemia: A Meta-Analysis.
Wahid FSA; Ismail NA; Wan Jamaludin WF; Muhamad NA; Mohamad Idris MA; Lai NM
Curr Stem Cell Res Ther; 2018; 13(4):265-283. PubMed ID: 29532760
[TBL] [Abstract][Full Text] [Related]
15. Review of the Long-term Effects of Autologous Bone-Marrow Mononuclear Cell Implantation on Clinical Outcomes in Patients with Critical Limb Ischemia.
Yusoff FM; Kajikawa M; Matsui S; Hashimoto H; Kishimoto S; Maruhashi T; Chowdhury M; Noma K; Nakashima A; Kihara Y; Sueda T; Higashi Y
Sci Rep; 2019 May; 9(1):7711. PubMed ID: 31118440
[TBL] [Abstract][Full Text] [Related]
16. [Preliminary Clinical Efficiency of Autologous Peripheral Blood Mononuclear Cells for Treating Critical Limb Ischemia of Thromboangiitis Obliterans].
Yu JY; Li SZ; Wu LH; Li HM; Gao WH; Zheng YL; Xu N; Liu QG; Li JF; Liu CH; Hu YM; Huang PP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Jun; 24(3):892-6. PubMed ID: 27342528
[TBL] [Abstract][Full Text] [Related]
17. Autologous bone marrow-derived mononuclear cell therapy in Chinese patients with critical limb ischemia due to thromboangiitis obliterans: 10-year results.
Guo J; Guo L; Cui S; Tong Z; Dardik A; Gu Y
Stem Cell Res Ther; 2018 Feb; 9(1):43. PubMed ID: 29471870
[TBL] [Abstract][Full Text] [Related]
18. Application of autologous bone marrow mononuclear cells in six patients with advanced chronic critical limb ischemia as a result of diabetes: our experience.
Subrammaniyan R; Amalorpavanathan J; Shankar R; Rajkumar M; Baskar S; Manjunath SR; Senthilkumar R; Murugan P; Srinivasan VR; Abraham S
Cytotherapy; 2011 Sep; 13(8):993-9. PubMed ID: 21671823
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic Angiogenesis Using Bone Marrow-Derived Mononuclear Cell Implantation for Patients With Critical Limb-Threatening Ischemia Caused by Thromboangiitis Obliterans - Study Protocol for a Multicenter Prospective Interventional Trial.
Fujioka A; Yanishi K; Shoji K; Hori Y; Kawamata H; Yukawa A; Yokota I; Teramukai S; Yamada A; Matoba S
Circ Rep; 2020 Sep; 2(10):630-634. PubMed ID: 33693187
[No Abstract] [Full Text] [Related]
20. Purified CD34
Dong Z; Pan T; Fang Y; Wei Z; Gu S; Fang G; Liu Y; Luo Y; Liu H; Zhang T; Hu M; Guo D; Xu X; Chen B; Jiang J; Yang J; Shi Z; Zhu T; Shi Y; Liu P; Fu W
EBioMedicine; 2018 Sep; 35():46-57. PubMed ID: 30172703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
